Correlation Between Travere Therapeutics and PTC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Travere Therapeutics and PTC Therapeutics, you can compare the effects of market volatilities on Travere Therapeutics and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and PTC Therapeutics.

Diversification Opportunities for Travere Therapeutics and PTC Therapeutics

0.84

Correlation Coefficient

Travere Therapeutics  PTC Therapeutics

Very poor diversification

The 3 months correlation between Travere and PTC is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and PTC Therapeutics go up and down completely randomly.

Pair Corralation between Travere Therapeutics and PTC Therapeutics

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 1.45 times less return on investment than PTC Therapeutics. In addition to that, Travere Therapeutics is 1.16 times more volatile than PTC Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. PTC Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest  3,647  in PTC Therapeutics on September 13, 2024 and sell it today you would earn a total of  1,320  from holding PTC Therapeutics or generate 36.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Travere Therapeutics  vs.  PTC Therapeutics

Travere Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

PTC Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Travere Therapeutics and PTC Therapeutics

The main advantage of trading using opposite Travere Therapeutics and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.

The idea behind Travere Therapeutics and PTC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.